Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-10-14
1977-07-26
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424251, 260250QN, 2602565R, 426532, C07D40312, A61K 31495
Patent
active
040383920
ABSTRACT:
2-Substituted-3-thiomethylheterocyclic-quinoxaline-1,4-dioxides are prepared from 2-substituted-3-bromomethyl-quinoxaline-1,4-dioxides and heterocyclic thiols. Oxidations yield the corresponding sulfoxides and sulfones. These compounds are effective in treating bacterial diseases in poultry, swine and cattle.
REFERENCES:
patent: 3558624 (1971-01-01), Ley et al.
patent: 3803145 (1974-04-01), Abushanab
patent: 3845047 (1974-10-01), Egli
patent: 3931174 (1976-01-01), McFarland
Berch Mark L.
Daus Donald G.
Pfizer Inc.
LandOfFree
3-(Heterocyclicthiomethyl) quinoxaline-1,4-dioxides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(Heterocyclicthiomethyl) quinoxaline-1,4-dioxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(Heterocyclicthiomethyl) quinoxaline-1,4-dioxides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-726844